BCL2A1 and chronic myelogenous leukemia, BCR-ABL1 positive: In a subsequent study, direct tetramer analysis was used to identify ACC-1-specific T cells in the bone marrow and peripheral blood in a patient who received an HLA-matched, ACC-1-disparate HCT for CML 14 months earlier (89).